Study compared ADHD medications for children; main difference relates to body weight

A comprehensive year-long study conducted by Australian researchers has compared the effects of methylphenidate and dextroamphetamine, the two most frequently prescribed medications for treating Attention Deficit Hyperactivity Disorder (ADHD) in children. The research aimed to evaluate the efficacy of these drugs in managing ADHD symptoms.

Children participating in the study were randomly assigned to receive either methylphenidate or dextroamphetamine. Researchers meticulously tracked their progress over the course of a year, observing how well each medication managed the core symptoms associated with ADHD, such as inattention, hyperactivity, and impulsivity.

While both medications demonstrated effectiveness in alleviating ADHD symptoms, a significant distinction emerged concerning their impact on the children's body weight. This finding suggests that clinicians and parents should consider potential weight-related side effects when choosing between these two widely used ADHD treatments.